News
As they have same origin, these hormones share some similarities, and hence the name ”glucagon-like”. The major sources of GLP-1 are the L-cells in the lining of small intestine.
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser (2)]exendin ...
COMMENTARY Glucagon-like Peptide 1: Incretin, Glucose Regulatory Hormone, and Diabetes Treatment, Part II Torsten P. Vahl, MD; David A. D'Alessio MD Disclosures May 07, 2004 0 ...
Overview of Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes Richard E. Pratley, MD Disclosures Medscape J Med. 2008;10 (7):171 0 ...
Novel Glucagon like peptide-1 (GLP-1) drugs were designed and industrial prepared by researchers from Hefei Institutes of Physical Science, Chinese Academy of Sciences Through molecular design ...
Correspondence Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas Published August 14, 2008 N Engl J Med 2008;359: 766 - 768 DOI: 10.1056/NEJMc0802045 ...
Addex Pharmaceuticals / Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors . Processed and transmitted by ...
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have ...
Glucagon-like peptide-1 receptor agonists related to adolescent weight loss, study suggests Date: February 4, 2013 Source: American Medical Association (AMA) Summary: Preliminary evidence from a ...
DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results